
AI Bite Back? IBM Crashes 13%!
AI fears intensify, tariff risks back, crypto tumbles, pharma shockwave — and Amazon still spending big. Here’s what Singapore investors should know before tonight’s US session 👇

📉Wall Street Slides Again — AI + Tariff Risk Combo
Overnight, all three major US indices closed down at least ~1%.
What dragged markets lower?
- Renewed AI disruption fears
- Escalating tariff war concerns (new 15% tariffs effective today)
- Financials and software stocks under heavy pressure
This isn’t just random volatility — the market is repricing:
👉 AI = productivity boom
BUT
👉 AI = disruption risk to incumbents
And now add geopolitical trade tension back into the mix.
Question for the community:
Are we seeing a healthy correction… or the start of broader de-risking?
🤖IBM Crashes 13% — 25-Year Worst Drop
IBM plunged 13% — its biggest drop in 25 years.
Trigger?
Reports suggest new products from Anthropic threaten traditional programming ecosystems.
If AI can directly generate and manage complex codebases:
- Legacy IT services models could face structural pressure.
- Enterprise software pricing power may weaken.
This is the first major example of AI directly hurting a blue-chip tech incumbent.
Is this an overreaction — or the beginning of AI cannibalisation?
₿ Bitcoin Breaks $64K — Risk Appetite Weakens
Bitcoin dropped below $64,000 intraday, hitting a 2-week low and falling more than 5% from the day’s high.
Crypto often acts as:
- Liquidity proxy
- Risk sentiment gauge
With macro + tariff uncertainty rising, traders appear to be reducing leverage.
Does BTC lead equities… or follow them?
💳PayPal Jumps on Takeover Interest
After losing nearly half its market value over the past year, PayPal jumped over 5% on potential acquisition interest.
Interesting dynamic:
- Once high-growth fintech darling
- Now valuation reset → becomes takeover target?
Value investors, this one’s for you.
Would you buy PYPL standalone… or only on M&A hopes?
🏗Amazon Investing $12B — AI Infrastructure Expanding
Despite entering bear market territory earlier this month, Amazon announced a $12B investment to build its first data center campus in Louisiana.
Translation:
- AI infrastructure buildout continues.
- Capex commitment not slowing.
Markets may punish Big Tech short-term…
But long-term AI arms race is still very real.
💊Pharma Shock: Novo Nordisk -16%, Eli Lilly +5%
Novo Nordisk plunged over 16% after data showed its next-gen weight loss drug underperformed expectations relative to Eli Lilly’s competing product.
Meanwhile, Lilly rose nearly 5%.
This sector has been one of the strongest multi-year themes. Now:
👉 Is leadership consolidating around Lilly?
👉 Or is the GLP-1 trade getting crowded?
📊HIMS Earnings — Stock Drops After Hours
Hims & Hers Health fell over 8% post-market following earnings.
Telehealth remains high-beta and sentiment-sensitive. Traders should watch if weakness spills over to growth healthcare names tonight.
🏛 Macro & Event Radar
📌 Donald Trump delivers State of the Union
📌 New 15% tariffs officially take effect
📌 Apple annual shareholder meeting
📌 Tempus AI (TEM) reports after hours
Macro + policy + earnings all collide in one session.
Volatility likely elevated.
🎁 COMMENT & EARN!
- Is this a temporary AI scare or structural shift?
- Would you buy IBM after a 25-year worst drop?
- BTC below $64K — buying opportunity or risk-off warning?
💬 Drop your thoughts, predictions, or trades below and earn 188 Task Coins!
🤫 Ps: You’ll get an extra 100 Task Coins if you comment and repost (as shown below).
‼️ Important ‼️
- No reward will be given for duplicate or similar content.
- Rewards will be issued within 1-2 working days.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
